Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Genitourinary 2CNS 2Other solid neoplasm 1Gynecologic 1Gastrointestinal 1

Conditions

Wilms Tumor 1Testicular Neoplasms 1Teratoma 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Retinoblastoma 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Neuroectodermal Tumors 1Neuroblastoma 1Medulloblastoma 1Liver Neoplasms 1Kidney Neoplasms 1Hepatoblastoma 1Glioma 1Ependymoma 1Desmoplastic Small Round Cell Tumor 1Chordoma 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Granulocyte Colony-Stimulating Factor 5Filgrastim 5Etoposide 4Busulfan 4Thiotepa 3Melphalan 3Ifosfamide 3Carboplatin 3Peripheral Blood Stem Cell Transplantation 2Mesna 2sargramostim 1omburtamab I-131 1etoposide phosphate 1entinostat 1becatecarin 1alvocidib 1Ursodeoxycholic Acid 1Thrombopoietin 1Thalidomide 1Tamoxifen 1Stem Cell Transplantation 1Sirolimus 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Paclitaxel 1Leukapheresis 1LY2940680 1Immunologic Techniques 1Fentanyl 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Medulloblastoma × Bone Marrow Transplantation × Other solid neoplasm × Clear all
NCT00003926 2017-11-29

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
13 enrolled
CNSGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcoma

Ovarian Germ Cell Cancer, Astrocytoma, Brain Neoplasms, Chordoma, Ependymoma, Glioma, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Hepatoblastoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡